Phil Skolnick - Publications, H-index & Citations

Phil Skolnick

Indivior

83H指数

529论文数

2.7W被引数

收录论文 87

发表时间

Response to: improvements to out-of-hospital cardiac arrest and opioid overdose treatment algorithms to enhance positive outcomes 回复：对院外心脏骤停和阿片类药物过量治疗算法的改进以增强积极结果

Emergency and Critical Care Medicine

IF0

2025-12-01

PREAI

Laffont, Celine M.; Skolnick, Phil; Dahan, Albert

Reversal of a synthetic opioid overdose: Insights from a validated translational model 合成阿片类药物过量逆转：来自一个经过验证的转化模型的见解

Neuropharmacology

IF4.6

2025-06-06

OAAI

Celine M. Laffont; Prasad Purohit; Amparo de la Peña; Phil Skolnick

Translational Modeling as a Tool to Evaluate the Effectiveness of Nalmefene in a Community Setting: A Critical Perspective 转化建模作为一种评估纳美芬在社区环境中有效性的工具：一种批判性视角

Clinical Pharmacology & Therapeutics

IF5.5

2025-04-08

OAAI

Celine M. Laffont; Amparo de la Peña; Phil Skolnick

Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-02-01

PREAI

Purohit, Prasad; Delcamp, Nash; Gonzalez-Garcia, Ignacio; Skolnick, Phil; Laffont, Celine

Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era

FRONTIERS IN PSYCHIATRY

IF3.2

2024-07-11

OAAI

Heidbreder, Christian; Greenwald, Mark K.; Le Foll, Bernard; Skolnick, Phil

Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest

FRONTIERS IN PSYCHIATRY

IF3.2

2024-06-17

OAAI

Laffont, Celine M.; Purohit, Prasad; Delcamp, Nash; Gonzalez-Garcia, Ignacio; Skolnick, Phil

Treatment of overdose in the synthetic opioid era

PHARMACOLOGY & THERAPEUTICS

IF12.5

2022-05-01

OAAI

Skolnick, Phil

Countermeasures for Preventing and Treating Opioid Overdose

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2020-11-29

OAAI

France, Charles P.; Ahern, Gerard P.; Averick, Saadyah; Disney, Alex; Enright, Heather A.; Esmaeli-Azad, Babak; Federico, Arianna; Gerak, Lisa R.; Husbands, Stephen M.; Kolber, Benedict; Lau, Edmond Y.; Lao, Victoria; Maguire, David R.; Malfatti, Michael A.; Martinez, Girardo; Mayer, Brian P.; Pravetoni, Marco; Sahibzada, Niaz; Skolnick, Phil; Snyder, Evan Y.; Tomycz, Nestor; Valdez, Carlos A.; Zapf, Jim

Cannabinoid1 (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose

JOURNAL OF NEURAL TRANSMISSION

IF4

2019-12-31

OAAI

Skolnick, Phil; Crystal, Roger

Be positive about negatives-recommendations for the publication of negative (or null) results

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2019-12-01

OAAI

Bespalov, Anton; Steckler, Thomas; Skolnick, Phil

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2019-11-01

OAAI

Krieter, Philip; Gyaw, Shwe; Crystal, Roger; Skolnick, Phil

The development of glutamate-based antidepressants is taking longer than expected

DRUG DISCOVERY TODAY

IF7.5

2018-10-01

OAAI

Garay, Ricardo; Zarate, Carlos A.; Cavero, Icilio; Kim, Yong-Ku; Charpeaud, Thomas; Skolnick, Phil

On the front lines of the opioid epidemic: Rescue by naloxone

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2018-09-01

OAAI

Skolnick, Phil

Medication development in opioid addiction: Meaningful clinical end points

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2018-03-28

PREAI

Volkow, Nora D.; Woodcock, Janet; Compton, Wilson M.; Throckmorton, Douglas C.; Skolnick, Phil; Hertz, Sharon; Wargo, Eric M.

The Opioid Epidemic: Crisis and Solutions

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY

IF0

2018-01-06

260

OAAI

Skolnick, Phil

From bench to bedside: mGluR2 positive allosteric modulators as medications to treat substance use disorders

PSYCHOPHARMACOLOGY

IF3.3

2016-12-20

PREAI

Acri, Jane B.; Cross, Alan J.; Skolnick, Phil

Re-energizing the Development of Pain Therapeutics in Light of the Opioid Epidemic

NEURON

IF15

2016-10-01

OAAI

Skolnick, Phil; Volkow, Nora D.

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2016-06-17

OAAI

Bespalov, Anton; Steckler, Thomas; Altevogt, Bruce; Koustova, Elena; Skolnick, Phil; Deaver, Daniel; Millan, Mark J.; Bastlund, Jesper F.; Doller, Dario; Witkin, Jeffrey; Moser, Paul; O'Donnell, Patricio; Ebert, Ulrich; Geyer, Mark A.; Prinssen, Eric; Ballard, Theresa; Macleod, Malcolm

Measures of outcome for stimulant trials: ACTTION recommendations and research agenda 兴奋剂试验结果的衡量标准: 行动建议和研究议程

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2016-01-01

OAAI

Kiluk, Brian D.; Carroll, Kathleen M.; Duhig, Amy; Falk, Daniel E.; Kampman, Kyle; Lai, Shengan; Litten, Raye Z.; McCann, David J.; Montoya, Ivan D.; Preston, Kenzie L.; Skolnick, Phil; Weisner, Constance; Woody, George; Chandler, Redonna; Detke, Michael J.; Dunn, Kelly; Dworkin, Robert H.; Fertig, Joanne; Gewandter, Jennifer; Moeller, F. Gerard; Ramey, Tatiana; Ryan, Megan; Silverman, Kenneth; Strain, Eric C.

Biologic Approaches to Treat Substance-Use Disorders

TRENDS IN PHARMACOLOGICAL SCIENCES

IF19.9

2015-10-01

OAAI

Skolnick, Phil

研究方向